Filing Flows › Escalon Medical (ESMC) › Q4 FY26 › vs Q3 FY26
Escalon Medical (ESMC) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Escalon Medical's revenue rose $1.3M (+48%) from $2.6M in Q3 FY26 to $3.9M in Q4 FY26. The biggest changes: Product +$1.2M (+48%); Service +$65K (+48%). Operating margin 14.7% against -16.1% (+30.8 pts).
Escalon Medical, Q4 FY26: revenue $3.9M (+50% year over year), operating margin 14.7%, net earnings $1.8M, operating cash flow −$251K. The chart draws each line against Q3 FY26, the increases inside each band.
Margins
| Q4 FY26 | Q3 FY26 | Change | |
|---|---|---|---|
| Operating margin | 14.7% | -16.1% | +30.8 pts |
| Net margin | 46.1% | 91.0% | -44.8 pts |
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Product | $3.7M | $2.5M | $1.2M | +48% |
| Service | $202K | $137K | $65K | +48% |
| Revenue | $3.9M | $2.6M | $1.3M | +48% |
| Other income, net | $73K | $2.8M | −$2.7M | -97% |
| Operating profit | $569K | −$419K | $988K | — |
| Costs & expenses | $3.3M | $3.0M | $265K | +9% |
| Pre-tax earnings | $642K | $2.4M | −$1.7M | -73% |
| Cost of revenue | $1.9M | $1.7M | $253K | +15% |
| Research & development | $124K | $30K | $94K | +316% |
| SG&A | $1.3M | $1.3M | −$83K | -6% |
| Income tax benefit | $1.1M | $0 | $1.1M | — |
| Net earnings | $1.8M | $2.4M | −$592K | -25% |
| Operating cash sources | $2.0M | $2.1M | −$60K | -3% |
| Depreciation & amortization | $3K | $3K | $1 | 0% |
| Cash used in operations | $251K | −$281K | $532K | — |
| Working capital & other | $2.0M | $2.1M | −$60K | -3% |
Questions
How much did Escalon Medical's revenue grow quarter over quarter in Q4 FY26?
Escalon Medical's revenue rose $1.3M (+48%) from $2.6M in Q3 FY26 to $3.9M in Q4 FY26.
What drove Escalon Medical's revenue change in Q4 FY26?
Product +$1.2M (+48%); Service +$65K (+48%).